Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Microvention Inc.

This article was originally published in Start Up

Executive Summary

Microvention Inc., a three-year-old start-up, is developing minimally invasive devices for treating cerebral vascular conditions. Its is first focusing on developing a better devices for treating aneurysms. It has a hybrid device, combining coils with a sponge-like hydrogel material that fills the aneurysm, cutting it off from the blood vessel. This allows the blood vessel to heal and recover its full strength. The product is in pre-clinical trials.

You may also be interested in...

Neurovascular Market's Time Has Come: Stealthy Sequent Medical Unveils Strategy

With foresight, good timing, or simply years of experience, the founders of Sequent Medical (who also founded MicroVention) are launching a new endovascular product in Europe just as large companies are signalling their interest in the space via acquisitions. For the treatment of cerebral aneurysms, Sequent has developed a novel device that combines the best attributes of embolization coils and flow diverters, its founders believe.

ATV Moves West Where the Devices Are

Advanced Technology Ventures, is an example of a venture firm that got into health care investing by initially focusing on medical devices in 1986. In order to remain closely involved with device start-ups, ATV has beefed up its presence in the hub of device innovation, the San Francisco area.

Podcast: Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space

Listen to expert perspectives from Tracey Parker, Vice President, Biometrics, Advanced Clinical and Rebecca Starkie, Senior Global Patient Engagement Director, Advanced Clinical on the recent history of DEI in clinical trials and the barriers to patient participation. Examine the key drivers that have influenced the development of diversity, equity, and inclusion programs for clinical trials.


Related Companies

Related Deals

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts